1. In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model

   • Fumihiko Kanzawa
   • Kazuto Nishio
   • Nagahiro Saijo

   ORIGINAL ARTICLE Pages: 353 - 363

2. Comparative brain tissue distribution of camptothecin and topotecan in the rat

   • Sanaa A. El-Gizawy
   • Mohsen A. Hedaya

   ORIGINAL ARTICLE Pages: 364 - 370

3. The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells

   • Janet E. Merritt
   • John A. Sullivan
   • Roger Warr

   ORIGINAL ARTICLE Pages: 371 - 378

4. A comparative study of administration methods of granisetron injection used to treat nausea/vomiting induced by cancer chemotherapy without cisplatin in tumors of hematopoietic organs

   • Noriyuki Tatsumi
   • Tohru Masaoka
   • on behalf of the Keihanshin Study Group of Hematological Malignancies

   ORIGINAL ARTICLE Pages: 379 - 384

5. A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days

   • Mark D. DeMario
   • Mark J. Ratain
   • David Lebwohl

   ORIGINAL ARTICLE Pages: 385 - 388

6. Sonodynamically induced effect of rose bengal on isolated sarcoma 180 cells

   • Shin-ichiro Umemura
   • Nagahiko Yumita
   • Ryuichiro Nishigaki

   ORIGINAL ARTICLE Pages: 389 - 393

7. Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells

   • Toshihiko Sunami
   • Kazuto Nishio
   • Nagahiro Saijo

   ORIGINAL ARTICLE Pages: 394 - 401

8. Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft

   • Steven Weitman
   • Gina Mangold
   • Daniel Von Hoff

   ORIGINAL ARTICLE Pages: 402 - 408

9. A pilot study of melphalan, tumor necrosis factor-α and 41.8 °C whole-body hyperthermia

   • H. I. Robins
   • D. M. Katschinski
   • F. d'Oleire

   ORIGINAL ARTICLE Pages: 409 - 414

10. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates

    • Baruti M. Serabe
    • Daryl J. Murry
    • Susan M. Blaney

    ORIGINAL ARTICLE Pages: 415 - 418

11. Pharmacology of N-benzyladriamycin-14-valerate in the rat

    • Trevor W. Sweatman
    • Ramakrishnan Seshadri
    • Mervyn Israel

    ORIGINAL ARTICLE Pages: 419 - 426

12. A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion

    • Harold J. Wanebo
    • James F. Belliveau

    ORIGINAL ARTICLE Pages: 427 - 434

13. A single 24-hour plasma sample does not predict the carboplatin AUC from carboplatin-paclitaxel combinations or from a high-dose carboplatin-thiotepa-cyclophosphamide regimen

    • Vinodh R. Nannan Panday
    • Laurence J. C. van Warmerdam
    • Jos H. Beijnen

    SHORT COMMUNICATION Pages: 435 - 438

14. Erratum: Cancer Chemother Pharmacol (1998) 42: 433–440

    Pages: 439 - 440